Fennec Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.24

+2.47 (+36.48%)

As of May 16, 2:02 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +222.5% upside

Low Target $21.84

Average Target $29.80

High Target $37.23

Current Price $9.24

Current
$9.24

Target
$29.80

$21.84 $29.80 avg $37.23

Scenario Analysis

Bear Case

$21.84

136.4%

Low target

Base Case

$29.80

+222.5%

Avg target

Bull Case

$37.23

+302.9%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$9.92

-6.9% from high

52-Week Low

$5.65

+63.5% from low

Target vs 52W High

$29.80

+200.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%